Analyst Report: RR.L
1. EXECUTIVE SUMMARY
Rolls-Royce fell 7.57% on Friday 23 October 2026 to close at 1,164.20p, the worst result on a day when the FTSE 100 slipped 0.32%. Sharecast, Marketscreener and Alliance News tie the drop to French peer Safran flagging slower aftermarket demand for wide-body jets, with jet-fuel costs adding to the concern. Thursday's 5.11% fall has no sourced cause, so the two sessions together took the stock down from 1,327.40p to 1,164.20p without a company-specific negative in the brief. Analyst targets were unchanged inside the window, and the next scheduled test is the trading update on 12 November 2026. The reading from here is that the market is pricing a possible hit to service revenue, which the company has yet to confirm or rebut.
2. THE CATALYST
Sharecast's midday report attributed the fall to Safran flagging a slowdown in wide-body jet demand. Marketscreener reported Safran down about 8% on worries that weaker aftermarket sales could extend into 2027, with airlines cutting capacity as fuel prices rose, and had Rolls-Royce down 6.4% mid-morning as the FTSE 100's worst performer. Alliance News, in its close report, put the stock at -7.6% after a weak response to Safran's results and jet-fuel cost concerns (via ad-hoc-news.de).
The macro backdrop was soft. Ad-hoc-news.de reported Brent crude above $115 and UK retail sales down 0.4% in September.
The FT reported before the London open that Rolls-Royce was nearing £100m to £200m of UK government funding for an UltraFan 30 demonstrator. Reuters could not verify the report and the company did not comment. The shares fell regardless.
| Session | Close | Change | Sourced cause |
|---|---|---|---|
| 21 Oct | 1,327.40p | +0.36% | None needed |
| 22 Oct | 1,259.60p | -5.11% | None found |
| 23 Oct | 1,164.20p | -7.57% | Safran aftermarket warning, fuel costs |
Sources disagree on the size of Friday's move (figures between -5.75% and -7.6%). The -7.57% in the market data governs. One 24 October ad-hoc-news.de article contains an obvious date error, and its claim that Safran kept full-year guidance rests on that article alone, so it is unverified. Sharecast describes softening growth and no source confirms a Safran guidance cut.
3. COMPANY PROFILE
Rolls-Royce Holdings is an Industrials company in Aerospace & Defense with three segments: Civil Aerospace (engines and aftermarket services for large commercial aircraft, regional jets and business aviation), Defence (military aero engines, naval engines and submarine nuclear power plants) and Power Systems. Its market capitalisation is £95.58bn.
H1 2026 results on 30 July showed underlying revenue up 26% to £11.3bn, underlying operating profit up 46% to £2.5bn at a 22.5% margin, and free cash flow up 24% to £2bn (The Twelfth Magpie). IBTimes reports that 2026 profit guidance was raised. The company is working through a £2.3bn buyback, with about 3.39m shares repurchased between 29 September and 5 October (Traders Union, undated), and announced a 70-engine Trent 7000 order from Avolon on 13 October (ad-hoc-news.de).
4. DEEP DIVE ANALYSIS
Do fundamentals justify the move? The brief contains no Rolls-Royce-specific deterioration. The latest reported results were strong and guidance was raised. The sell-off rests on read-across from Safran, and sources frame the open question as how far the slowdown reaches Rolls-Royce's own service revenue (Marketscreener). That is plausible for a company with a large civil aftermarket business, though it is my inference and no source quantifies it.
Peers and sector. Sector sources put aerospace and defence down about 4.6% at the close, with Marketscreener noting the lowest level since late May. Among UK peers, MRO.L fell 4.72%, BAB.L 0.61% and BA.L rose 0.08%. Sources do not explain the divergence. My inference is that the defence-weighted names carry less exposure to civil aftermarket demand, which fits the smaller moves at BAB.L and BA.L, while MRO.L's decline is close to the sector figure.
Context. The shares were already about 26% below their August peak before Friday (IBTimes), and the 13 October session (-3.58%) also has no sourced cause. Over 20 sessions the stock is down 21.41%. No earlier episode with a similar trigger appears in the brief.
Bull case. Results and guidance were strong, the forward P/E is 23.0 against a trailing 32.3, six brokers average a 1,690.33p target (five Buy, one Hold, range 1,325p to 1,900p, unchanged from a month earlier per MarketBeat), RBC holds Buy with a 1,600p target, and a possible UK funding award for UltraFan 30 would add to the narrowbody story.
Bear case. Aftermarket weakness at Safran could extend into 2027, airlines are trimming capacity as fuel rises, Brent is above $115, and two unexplained heavy-volume sessions suggest sellers who may not be finished. The government funding report is unverified.
5. TECHNICAL SNAPSHOT
The close of 1,164.20p is the lowest in the ten-session table, so no nearby support level shows in recent closes. It sits below both the 50-day average (1,446.54p) and the 200-day average (1,336.59p), and 26% under the 52-week high of 1,586.00p set on 6 August, though well above the 52-week low of 989.96p from 20 May. Volume of 40,179,078 was 2.21x the 50-session average of 18,140,661, and Thursday's 41,591,676 was higher still, which marks both falls as heavily traded. The session low of 1,158.60p was close to the final price, so sellers held control into the close.
6. RISK FACTORS
- Further evidence of a wide-body aftermarket slowdown, from other suppliers or airlines.
- Jet-fuel costs staying high and airlines cutting capacity further.
- Continuing technical selling after two sessions of heavy volume and a break below both averages.
- Government funding for UltraFan 30 remaining unconfirmed. The FT report is unverified, and an announcement was said to be possible as early as the week after 23 October.
- 12 November 2026: scheduled trading update, the first company-sourced read on service revenue since the Safran warning.
7. ACTIONABLE OUTLOOK
Short term (1-2 weeks): Direction depends on sentiment toward the sector and on any government funding announcement. Without a company statement the shares trade on read-across, and the heavy volume points to continued volatility. A confirmed funding award would help sentiment, and further peer warnings would add pressure.
Medium term (1-3 months): The 12 November trading update decides the matter. Commentary on aftermarket flight hours and 2026 guidance would show whether Safran's weakness reaches Rolls-Royce. Reaffirmed guidance would address the main worry behind the sell-off, while any softening would validate it.
Long term: The thesis has not changed on the evidence in the brief, since H1 results, raised guidance, the buyback and broker targets all pre-date the fall and remain in place. The valuation has compressed and the demand outlook has become less certain. This is analysis only and not personal financial advice.